We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.
INFI

Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

3 hedge funds and large institutions have $2.9K invested in Infinity Pharmaceuticals, Inc. in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% less funds holding

Funds holding: 45 → 3 (-42)

95% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 44

100% less capital invested

Capital invested by funds: $4.23M → $2.9K (-$4.23M)

Holders
3
Holders Change
-42
Holders Change %
-93.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
44
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$24K
2
HCM
Highlander Capital Management
New Jersey
+$464

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$1.34M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$838K
3
SFM
Sphera Funds Management
Israel
-$311K
4
BlackRock
BlackRock
New York
-$308K
5
CC
Carlson Capital
Texas
-$274K
Name Holding Trade Value Shares
Change 		Change in
Stake
XT
1
XTX Topco
Cayman Islands
$2.9K +$24K +181,068 New
SPIA
2
Steward Partners Investment Advisory
New York
$2 – – –
BI
3
BVF Inc
California
– -$1.34M -6,353,645 Closed
Vanguard Group
4
Vanguard Group
Pennsylvania
– -$838K -3,981,857 Closed
SFM
5
Sphera Funds Management
Israel
– -$311K -1,476,000 Closed
BlackRock
6
BlackRock
New York
– -$308K -1,461,881 Closed
CC
7
Carlson Capital
Texas
– -$274K -1,300,000 Closed
Mariner
8
Mariner
Kansas
– -$252K -1,195,000 Closed
Geode Capital Management
9
Geode Capital Management
Massachusetts
– -$170K -807,517 Closed
E
10
Ergoteles
New York
– -$147K -696,506 Closed
Renaissance Technologies
11
Renaissance Technologies
New York
– -$75K -358,200 Closed
State Street
12
State Street
Massachusetts
– -$70.4K -334,360 Closed
Fidelity Investments
13
Fidelity Investments
Massachusetts
– -$55.3K -262,473 Closed
Millennium Management
14
Millennium Management
New York
– -$52.7K -250,560 Closed
BL
15
Bleichroeder LP
New York
– -$52.6K -250,000 Closed
WIM
16
Wittenberg Investment Management
Massachusetts
– -$48.3K -229,000 Closed
EWM
17
Evercore Wealth Management
New York
– -$45.3K -215,403 Closed
Northern Trust
18
Northern Trust
Illinois
– -$35.4K -168,040 Closed
CC
19
Callan Capital
California
– -$33.4K -158,500 Closed
Franklin Resources
20
Franklin Resources
California
– -$26.3K -124,968 Closed
Two Sigma Advisers
21
Two Sigma Advisers
New York
– -$12.4K -58,900 Closed
Morgan Stanley
22
Morgan Stanley
New York
– -$9.48K -45,025 Closed
PAG
23
Private Advisor Group
New Jersey
– -$8.44K -40,100 Closed
Two Sigma Investments
24
Two Sigma Investments
New York
– -$8.29K -39,405 Closed
Russell Investments Group
25
Russell Investments Group
United Kingdom
– -$7.98K -37,900 Closed
1
2

INFI Hedge Fund Activity: Q3 2023 in Review

3 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q3 2023, worth a combined $2.9K — down 100% from $4.23M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of INFI and 2 opened new positions — a net loss of 42 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was XTX Topco, opening a new position worth an estimated $24K. The largest seller was BVF Inc, exiting entirely with an estimated $1.34M sold.

  • 3 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q3 2023, down from 45 in Q2 2023.
  • Funds reported $2.9K of Infinity Pharmaceuticals, Inc. stock for Q3 2023, down 100% quarter-over-quarter.
  • 2 funds opened new Infinity Pharmaceuticals, Inc. positions in Q3 2023 and 44 closed out, a net change of -42 holders.
  • The largest Infinity Pharmaceuticals, Inc. buyer in Q3 2023 was XTX Topco, an estimated $24K added.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q3 2023 was BVF Inc, an estimated $1.34M sold.

Based on aggregated 13F filings for Q3 2023.